Vital Chemtech Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
VITAL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Vital Chemtech Limited reported audited standalone revenue of ₹10,525.59 Lakhs for FY2026, down from ₹12,022.87 Lakhs in FY2025, representing approximately 12.5% revenue decline. Consolidated revenue stood at ₹12,644.16 Lakhs versus ₹13,390.37 Lakhs previously. Standalone PAT was ₹244.08 Lakhs while consolidated PAT was ₹84.26 Lakhs. The company has two subsidiaries - Vital Alkoxide Private Limited and Vital Synthesis Limited. Statutory auditors Abhishek Kumar & Associates issued an unmodified (clean) opinion on both standalone and consolidated financials. The company also appointed M/s R J & Associates as Cost Auditor for FY2026-27. Cash flow from operations remained positive at ₹670.94 Lakhs standalone.
Revenue decline of around 12.5% on standalone basis is a concern for investors. However, clean audit opinion with positive operating cashflow provides some comfort. The stock may face pressure due to topline contraction.